Características clinicoepidemiológicas de los pacientes recién diagnosticados de infección por el VIH

López de Munain, Josefina; Santamaría, Juan Miguel; Cámara, M. Mar; Zubero, Zuriñe.
Med. clín (Ed. impr.) ; 119(6): 238-239, jul. 2002.
Artículo en Es | IBECS (España) | ID: ibc-13211

Documentos relacionados

  1. Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis.
  2. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial.
  3. Synthesis, Biological, Spectroscopic and Computational Investigations of Novel <i>N</i>-Acylhydrazone Derivatives of Pyrrolo[3,4-<i>d</i>]pyridazinone as Dual COX/LOX Inhibitors.
  4. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen.
  5. COX Postulates: Remember the Fibroblast.
  6. Formulation of Aloe vera based curcumin topical gel and its in-vitro evaluation.
  7. Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation.
  8. Mollusc-Derived Brominated Indoles for the Selective Inhibition of Cyclooxygenase: A Computational Expedition.
  9. Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury.
  10. COX-1 Inhibitors: Beyond Structure Toward Therapy.